Olatec Therapeutics
PrivateLast Round
Series B
Nov 9, 2025
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Olatec Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Grant round in July 2024.
Olatec Therapeutics is a biopharmaceutical company that develops oral small-molecule therapeutics targeting the NLRP3 inflammasome and Interleukin-1 pathways to treat inflammatory and immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Olatec Therapeutics Comparables
Compare Olatec Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NodThera | 87% | |
| IFM Therapeutics | 86% | |
| Halia Therapeutics | 86% |
For institutional investors. Book with your work email.
Olatec Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 9, 2025 | ||||
| Grant | Jul 11, 2024 | ||||
| Grant | Feb 20, 2024 | ||||
| Grant | Mar 10, 2023 | ||||
| Series A | Feb 23, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Olatec Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advection Growth Capital | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Cure Parkinson's | Grant |
| Van Andel Institute | Grant |
| European Union | Grant |
| Sanders Morris Harris | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 156% MoM.
- Oct 2, 2025
Andy Cunningham joins the Board of Directors.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 15, 2026
Olatec Therapeutics Llc. appoints physician-innovator David Haase to its Board of Directors and Clinical Advisory Board on Sep 15th '26 in New York.
For institutional investors. Book with your work email.
Olatec Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Olatec Therapeutics's valuation, stock price, and market status.
Is Olatec Therapeutics a public or private company?
Olatec Therapeutics is a private company.
What is the current stock price of Olatec Therapeutics?
Olatec Therapeutics is a private company, so its shares have no public market price. Caplight tracks Olatec Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Olatec Therapeutics worth (valuation)?
Valuation information for Olatec Therapeutics is not publicly available.
Can I buy Olatec Therapeutics stock?
Olatec Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Olatec Therapeutics's last funding round?
Olatec Therapeutics's most recent funding round was Series B on November 9, 2025.
Who are the main investors in Olatec Therapeutics?
Key investors in Olatec Therapeutics include Cure Parkinson's, Sanders Morris Harris.
Will Olatec Therapeutics IPO soon?
No public IPO plans have been announced for Olatec Therapeutics.
How can I track Olatec Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Olatec Therapeutics's shares on secondary markets.